WO2014195861A3 - Preparation of ticagrelor - Google Patents
Preparation of ticagrelor Download PDFInfo
- Publication number
- WO2014195861A3 WO2014195861A3 PCT/IB2014/061912 IB2014061912W WO2014195861A3 WO 2014195861 A3 WO2014195861 A3 WO 2014195861A3 IB 2014061912 W IB2014061912 W IB 2014061912W WO 2014195861 A3 WO2014195861 A3 WO 2014195861A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ticagrelor
- preparation
- intermediates
- processes
- present application
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Ceramic Products (AREA)
Abstract
The present application relate to processes for preparing Ticagrelor and its intermediates.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP14807111.1A EP3004113A2 (en) | 2013-06-04 | 2014-06-03 | Preparation of ticagrelor |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN2434/CHE/2013 | 2013-06-04 | ||
IN2434CH2013 | 2013-06-04 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2014195861A2 WO2014195861A2 (en) | 2014-12-11 |
WO2014195861A3 true WO2014195861A3 (en) | 2015-04-02 |
Family
ID=52008665
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2014/061912 WO2014195861A2 (en) | 2013-06-04 | 2014-06-03 | Preparation of ticagrelor |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP3004113A2 (en) |
WO (1) | WO2014195861A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI229674B (en) | 1998-12-04 | 2005-03-21 | Astra Pharma Prod | Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses |
US10017515B2 (en) * | 2014-08-11 | 2018-07-10 | Sun Pharmaceutical Industries Limited | Stable amorphous ticagrelor and a process for its preparation |
WO2016030704A1 (en) * | 2014-08-30 | 2016-03-03 | Cipla Limited | Solid form of intermediate of ticagrelor |
CN110183436A (en) * | 2019-06-21 | 2019-08-30 | 南通常佑药业科技有限公司 | A kind of preparation method of armorphous Ticagrelor |
CN110684019B (en) * | 2019-10-29 | 2020-08-18 | 株洲千金药业股份有限公司 | Preparation method of ticagrelor intermediate oxide impurity |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030148888A1 (en) * | 2000-06-02 | 2003-08-07 | Ulf Larsson | Novel triazolo pyrimidine compounds |
US7265124B2 (en) * | 2000-06-02 | 2007-09-04 | Astrazeneca Ab | Cristalline and amorphous form of a triazolo (4,5-D) pyridimine compound |
-
2014
- 2014-06-03 EP EP14807111.1A patent/EP3004113A2/en not_active Withdrawn
- 2014-06-03 WO PCT/IB2014/061912 patent/WO2014195861A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030148888A1 (en) * | 2000-06-02 | 2003-08-07 | Ulf Larsson | Novel triazolo pyrimidine compounds |
US7265124B2 (en) * | 2000-06-02 | 2007-09-04 | Astrazeneca Ab | Cristalline and amorphous form of a triazolo (4,5-D) pyridimine compound |
Also Published As
Publication number | Publication date |
---|---|
EP3004113A2 (en) | 2016-04-13 |
WO2014195861A2 (en) | 2014-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3060041A4 (en) | Prostacyclin compounds, compositions and methods of use thereof | |
EP2970091A4 (en) | Solid forms of treprostinil | |
EP3021843A4 (en) | Anti-viral compounds, pharmaceutical compositions, and methods of use thereof | |
EP2998299A4 (en) | Preparation method of azoxystrobin | |
EP2999708A4 (en) | Processes for the preparation of dehydroepiandrosterone and its intermediates | |
WO2014147640A3 (en) | Process for the preparation of anagliptin | |
IL241758B (en) | Preparation of pyrimidine intermediates useful for the manufacture of macitentan | |
EP3055281A4 (en) | Preparation of hydroxy-benzylbenzene derivatives | |
EP2971029C0 (en) | Preparation of malto-oligosaccharides | |
EP3049079A4 (en) | Solid forms of ceftolozane | |
HK1213882A1 (en) | Process and intermediates for the preparation of pregabalin | |
IL244755A0 (en) | L process for the preparation of xanthohumol | |
HK1202533A1 (en) | Intermediates of ticagrelor and the preparation methods and for the preparation of ticagrelor | |
WO2014195861A3 (en) | Preparation of ticagrelor | |
EP3013848A4 (en) | Process for the preparation of abiraterone and intermediates thereof | |
EP3016935A4 (en) | Process for the preparation of intermediate of dolutegravir | |
EP3068770A4 (en) | Processes for the preparation of pyrimidinylcyclopentane compounds | |
EP3060546A4 (en) | Processes for the preparation of unsaturated esters | |
EP3045440A4 (en) | Method for the preparation of trichloromethyl-group-substituted benzene | |
EP3027622B8 (en) | Process for the preparation of oxymorphone | |
EP2984055A4 (en) | Preparation of surfactants via cross-metathesis | |
HK1217670A1 (en) | Formulations of albu-bche, preparation and uses thereof albu-bche | |
EP3056491A4 (en) | Synthetic intermediate of maxacalcitol, preparation method therefor and use thereof | |
WO2014145302A3 (en) | Synthesis of ent-progesterone and intermediates thereof | |
EP3024440A4 (en) | Formulation of metaxalone |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REEP | Request for entry into the european phase |
Ref document number: 2014807111 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2014807111 Country of ref document: EP |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14807111 Country of ref document: EP Kind code of ref document: A2 |